HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 277, Issue 40, 37929-37935, October 4, 2002

This Article Full Text Full Text (PDF) All Versions of this Article: 277/40/37929    most recent M202245200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Villalonga, P. Articles by Agell, N. Search for Related Content PubMed PubMed Citation Articles by Villalonga, P. Articles by Agell, N. Social Bookmarking                      What's this?

Calmodulin Prevents Activation of Ras by PKC in 3T3 Fibroblasts^*

Priam Villalonga^§¶, Cristina López-Alcalá^¶, Antonio Chiloeches^**, Joan Gil, Richard Marais^**, Oriol Bachs, and Neus Agell^§§

From the  Departament de Biologia Cel·lular i Anatomia Patològica, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Facultat de Medicina, Universitat de Barcelona, 08036 Barcelona, Spain, the ^** Cancer Research Campaign (CRC) Center for Cell and Molecular Biology, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, United Kingdom, and the  Departament de Ciències Fisiològiques II, Campus de Bellvitge, Universitat de Barcelona, 08907 L'Hospitalet, Barcelona, Spain

We have shown previously (Villalonga, P., López- Alcalá, C., Bosch, M., Chiloeches, A., Rocamora, N., Gil, J., Marais, R., Marshall, C. J., Bachs, O., and Agell, N. (2001) Mol. Cell. Biol. 21, 7345-7354) that calmodulin negatively regulates Ras activation in fibroblasts. Hence, anti-calmodulin drugs (such as W13, trifluoroperazine, or W7) are able to induce Ras/ERK pathway activation under low levels of growth factors. We show here that cell treatment with protein kinase C (PKC) inhibitors abolishes W13-induced activation of Ras, Raf-1, and ERK. Consequently, PKC activity is essential for achieving the synergism between calmodulin inhibition and growth factors to activate Ras. Furthermore, whereas the activation of PKC by 12-O-tetradecanoylphorbol-13-acetate (TPA) does not induce Ras activation in 3T3 cells, activation is observed if calmodulin is simultaneously inhibited. This indicates that calmodulin is preventing Ras activation by PKC. Treatment of cells with epidermal growth factor receptor or platelet-derived growth factor receptor tyrosine kinase inhibitors does not abrogate the activation of Ras by calmodulin inhibition. This implies that epidermal growth factor receptor and platelet-derived growth factor receptor tyrosine kinase activities are dispensable for the activation of Ras by TPA plus W13, and, therefore, Ras activation is not a consequence of the transactivation of those receptors by the combination of the anti-calmodulin drug plus TPA. Furthermore, K-Ras, the isoform previously shown to bind to calmodulin, is the only one activated by TPA when calmodulin is inhibited. These data suggest that direct interaction between K-Ras and calmodulin may account for the inability of PKC to activate Ras in 3T3 fibroblasts. In vitro experiments showed that the phosphorylation of K-Ras by PKC was inhibited by calmodulin, suggesting that calmodulin-dependent modulation of K-Ras phosphorylation by PKC could be the mechanism underlying K-Ras activation in fibroblasts treated with TPA plus W13.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				C. Lopez-Alcala, B. Alvarez-Moya, P. Villalonga, M. Calvo, O. Bachs, and N. Agell Identification of Essential Interacting Elements in K-Ras/Calmodulin Binding and Its Role in K-Ras Localization J. Biol. Chem., April 18, 2008; 283(16): 10621 - 10631. [Abstract] [Full Text] [PDF]

				J. Liao, S. M. Planchon, J. C. Wolfman, and A. Wolfman Growth Factor-dependent AKT Activation and Cell Migration Requires the Function of c-K(B)-Ras Versus Other Cellular Ras Isoforms J. Biol. Chem., October 6, 2006; 281(40): 29730 - 29738. [Abstract] [Full Text] [PDF]

				M. S. Roberson, S. P. Bliss, J. Xie, A. M. Navratil, T. A. Farmerie, M. W. Wolfe, and C. M. Clay Gonadotropin-Releasing Hormone Induction of Extracellular-Signal Regulated Kinase Is Blocked by Inhibition of Calmodulin Mol. Endocrinol., September 1, 2005; 19(9): 2412 - 2423. [Abstract] [Full Text] [PDF]

				S. A. Walker and P. J. Lockyer Visualizing Ras signalling in real-time J. Cell Sci., June 15, 2004; 117(14): 2879 - 2886. [Abstract] [Full Text] [PDF]

				M. Illario, A. L. Cavallo, K. U. Bayer, T. Di Matola, G. Fenzi, G. Rossi, and M. Vitale Calcium/Calmodulin-dependent Protein Kinase II Binds to Raf-1 and Modulates Integrin-stimulated ERK Activation J. Biol. Chem., November 14, 2003; 278(46): 45101 - 45108. [Abstract] [Full Text] [PDF]